On friday bby increased the target for acrux to $4.10 from $3.60.They expect sales from axiron to peak at $1.1 billion in fy17.With the approval of ellavie in sweden they say that this should lead to approval in most major european countries within 6 months.They also expect acr to appoint a distribution partner in europe and to earn a royalty of at least 20%.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $6.116M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $1.154K | 76.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 387316 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 388346 | 2 |
View Market Depth
| Last trade - 10.59am 26/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |